About Numira
Numira is a company based in Salt Lake City (United States) founded in 2005 by Michael Beeuwsaert and David Weinstein. It operates as a B2B. Numira has raised $5.78 million across 2 funding rounds from investors including Pasadena Angels, Tech Coast Angels and Signal Peak. Numira operates in a competitive market with competitors including Pulse Medical Imaging Technology, Asterand Bioscience, StageBio, Radiomics and Keen Eye, among others.
- Headquarter Salt Lake City, United States
- Founders Michael Beeuwsaert, David Weinstein
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$5.78 M (USD)
in 2 rounds
-
Latest Funding Round
$3.28 M (USD), Series A
May 26, 2009
-
Investors
Pasadena Angels
& 2 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Numira
Numira has successfully raised a total of $5.78M across 2 strategic funding rounds. The most recent funding activity was a Series A round of $3.28 million completed in May 2009. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Numira
Numira has secured backing from 3 investors, including venture fund investors. Prominent investors backing the company include Pasadena Angels, Tech Coast Angels and Signal Peak.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Investments are facilitated by Pasadena Angels in Southern California startups.
|
Locked | Locked | Locked | |
|
Angel Network for companies based in Southern California
|
Locked | Locked | Locked | |
|
Early-stage investments in US tech and life sciences are targeted.
|
Locked | Locked | Locked |
Investor details for Numira
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Numira
Investment portfolio details for Numira
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Numira
Detailed financials for Numira
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Numira Comparisons
Peer comparison for Numira
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Numira
Numira operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Pulse Medical Imaging Technology, Asterand Bioscience, StageBio, Radiomics and Keen Eye, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Cardiac imaging services are offered by CRO in Shanghai.
|
|
| Locked | Locked | Locked |
Human tissue solutions for drug discovery research are supplied globally.
|
|
| Locked | Locked | Locked |
Preclinical pathology services are provided for research and development needs.
|
|
| Locked | Locked | Locked |
Provider of clinical trials support & software services for medical devices manufacturers
|
|
| Locked | Locked | Locked |
Manufacturer of drug development services for image analysis
|
Detailed competitors of Numira
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Numira
Complete news archive for Numira
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Numira
Numira was founded in 2005 and raised its 1st funding round 2 years after it was founded.
Numira is headquartered in Salt Lake City, United States. It is registered at Salt Lake City, Utah, United States.
Numira is a funded company, having raised a total of $5.78M across 2 funding rounds to date.
Numira numira is a specialty preclinical cro specializing in microct imaging, image analysis, histology, and 3d cancer cell profiling through healthcare and biotechnology, clinical research, preclinical services, and imaging and analysis. Prioritizing client-centric approaches, it ensures high-quality outcomes, innovation, and sustainable practices in its field.
Numira's top competitors include Asterand Bioscience, Pulse Medical Imaging Technology and Radiomics.
Numira has 3 investors. Key investors include Pasadena Angels, Tech Coast Angels, and Signal Peak.